A phantom study: Evaluation of a novel three-lumen balloon catheter for potential treatment of intractable limb

Efecan Tatarlar1, Emir Yusuf2, Özgür Kocatürk1

  • 1Bogazici University, Kandilli, Rasathane Cd. No:104 D:7, Üsküdar, Istanbul, 34684, Turkey.

Insights

A novel Hyper Perfusion Catheter effectively increased ankle pressure in a critical limb ischemia (CLI) model. This device shows promise for treating peripheral arterial disease (PAD) by improving blood flow and potentially preventing limb loss.

Area of Science:

  • Biomedical Engineering
  • Vascular Surgery
  • Medical Device Design

Background:

  • Critical limb ischemia (CLI) is a severe manifestation of peripheral arterial disease (PAD), often leading to limb loss.
  • Low ankle systolic pressure (≤50 mmHg) is a key indicator of CLI.
  • Current treatments aim to restore blood flow and alleviate ischemic pain.

Purpose of the Study:

  • To design and fabricate a novel three-lumen catheter with a distal inflatable balloon, based on the Hyper Perfusion Catheter design.
  • To evaluate the efficacy of the proposed catheter in increasing ankle systolic pressure in an in vitro critical limb ischemia model.
  • To assess the impact of the device on systemic pressure.

Main Methods:

  • A custom 9 Fr, three-lumen catheter with an integrated inflatable balloon was designed and fabricated.
  • An in vitro critical limb ischemia (CLI) model phantom was constructed using a modified hemodialysis circuit and pump.
  • Experiments utilized a blood-mimicking fluid and real-time data collection, verified by medical devices.

Main Results:

  • The custom catheter successfully elevated distal pressure (simulating ankle pressure) to over 80 mmHg in the in vitro CLI model.
  • The significant pressure increase was achieved without adversely affecting systemic pressure.
  • The device demonstrated feasibility in a simulated peripheral arterial disease scenario.

Conclusions:

  • The Hyper Perfusion Catheter design is effective in significantly increasing ankle systolic pressure in a simulated critical limb ischemia environment.
  • This novel device holds potential for improving healing and pain management in CLI patients.
  • Further research and clinical trials are warranted to validate these findings in patients with peripheral arterial disease.